| P50 | author | Dennis Discher | Q42675760 |
| P2093 | author name string | Abdullah Mahmud | |
| P2860 | cites work | The lung as a route for systemic delivery of therapeutic proteins and peptides | Q24792013 |
| | Mechanisms of alveolar epithelial translocation of a defined population of nanoparticles | Q28395780 |
| | Regulated portals of entry into the cell | Q29547391 |
| | Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus | Q30478934 |
| | Rapid translocation of nanoparticles from the lung airspaces to the body | Q30498755 |
| | New polymeric carriers for controlled drug delivery following inhalation or injection | Q30721607 |
| | Inhibition of lung tumor growth by complex pulmonary delivery of drugs with oligonucleotides as suppressors of cellular resistance | Q33934763 |
| | Targeting endothelium and its dynamic caveolae for tissue-specific transcytosis in vivo: a pathway to overcome cell barriers to drug and gene delivery | Q34011941 |
| | PECAM‐targeted delivery of SOD inhibits endothelial inflammatory response | Q34421779 |
| | Mucus clearance as a primary innate defense mechanism for mammalian airways | Q34551378 |
| | Clinical pharmacokinetics and pharmacodynamics of inhaled insulin | Q35881751 |
| | Functional and morphological studies of protein transcytosis in continuous endothelia | Q35913804 |
| | Exotic emerging viral diseases: progress and challenges | Q35971398 |
| | Host cell dependence of viral morphology | Q36097986 |
| | Prophylactic thrombolysis by thrombin-activated latent prourokinase targeted to PECAM-1 in the pulmonary vasculature | Q36445835 |
| | Inhaled cytokines and cytokine antagonists | Q36615414 |
| | Inhaling medicines: delivering drugs to the body through the lungs | Q36694800 |
| | Nanoparticles for drug delivery to the lungs | Q36998692 |
| | Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues | Q37153923 |
| | Nanoparticle formulations in pulmonary drug delivery | Q37311123 |
| | Shape effects of filaments versus spherical particles in flow and drug delivery | Q37338776 |
| | Enhanced efficacy of local etoposide delivery by poly(ether-anhydride) particles against small cell lung cancer in vivo | Q37442003 |
| | Systemic delivery of parathyroid hormone (1-34) using inhalation dry powders in rats | Q38355304 |
| | The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation. | Q39864089 |
| | Characterization of avian H5N1 influenza viruses from poultry in Hong Kong | Q40829809 |
| | The M1 and M2 proteins of influenza A virus are important determinants in filamentous particle formation | Q41068623 |
| | Endocytosis and transcytosis | Q41739251 |
| | Hydrolytic degradation of poly(ethylene oxide)-block-polycaprolactone worm micelles | Q43191394 |
| | Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs | Q44366328 |
| | Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes: results of a 6-month, randomized, comparative trial | Q45124465 |
| | Targeting efficiency and biodistribution of biotinylated-EGF-conjugated gelatin nanoparticles administered via aerosol delivery in nude mice with lung cancer | Q46627272 |
| | A comparison of the pulmonary bioavailability of powder and liquid aerosol formulations of salmon calcitonin | Q46743057 |
| | The cost of delivering drugs without needles | Q47941170 |
| | Pulmonary delivery of insulin by liposomal carriers. | Q51191833 |
| | Pharmacokinetics and pharmacodynamics of inhaled versus intravenous morphine in healthy volunteers. | Q51382697 |
| P433 | issue | 8 | |
| P304 | page(s) | 607-612 | |
| P577 | publication date | 2011-06-30 | |
| P1433 | published in | IUBMB Life | Q15764029 |
| P1476 | title | Lung vascular targeting through inhalation delivery: insight from filamentous viruses and other shapes | |
| P478 | volume | 63 | |